ÌÇÐÄvlog´«Ã½

France Computed Tomography Market Analysis

The France Computed Tomography Market size is estimated at USD 397.45 million in 2024, and is expected to reach USD 533.88 million by 2029, growing at a CAGR of 6.08% during the forecast period (2024-2029).

The COVID pandemic had an adverse impact on market growth. Various research studies have been published to provide insight into market growth during the pandemic. For instance, The number of CT scans for the chest and thoracic region increased during the COVID surge period, according to a research released in July 2020 titled "COVID-19 impact assessment on the French radiological centers: a statewide survey." A total of 108,959 chests CTs were performed, 56,110 of which were done in France for COVID. Because 52.8 percent of radiologic structures followed the French recommendations to dedicate devices to COVID-19, there were fewer CT devices and more COVID-19 patients, which limited access to other pathologies, and there was a 50-80% decrease in the total number of CT scans in private centers as a result of COVID-19.

The COVID-19 infection should be diagnosed by mobile X-ray and CT (computed tomography) scans, according to the French Society of Radiology (Société Française de Radiologie - SFR). Healthcare providers and CT equipment makers have advantages thanks to COVID-19. Chest imaging has been examined as an alternate treatment for persons with suspected or likely COVID-19 when laboratory testing (RT-PCR) is not available, results are delayed, or results are initially negative. As a result, the need for CT scan imaging is anticipated to increase in the nation during the post-pandemic period. Amandine Crombé et al. reported in a July 2021 paper that out of a total of 100,018 CT scans over 36 weeks, 19,133 (19%) were completed in France using the COVID-19 procedure. The week of 2020-03-23 had the first wave's peak activity in terms of the number of CT scans in the COVID-19 workflow and the percentage of activity (1086 CT scans, 53.1 percent activity percentage). According to the research, comprehending the COVID-19 epidemic can be related to the weekly number of hospitalizations and CT scans performed. Thus, the market is expected to increase in the future.

The French computed tomography market is majorly driven by higher incidences of chronic diseases, such as chronic kidney disease. The country's market is also driven by the growing geriatric population, growing R&D procedures, and the increase in product launches. The prevalence of chronic renal failure in adults aged 18 to 74 years was estimated to be 1.5% using the chronic kidney disease epidemiology collaboration (CKD-Epi) formula and 2.1% using the European kidney function consortium (EKFC) formula, according to the report "Prevalence of Chronic Kidney Disease in France" published in October 2021. According to the CKD-EPI and EKFC equations, the prevalence was higher in women than in males and rose with age, reaching 6.5 percent and 9.9 percent in 65-74 years, respectively. As a result, the nation's high prevalence of chronic diseases will greatly fuel market expansion.

According to data provided by Eurostat, 13.1 million CT scans were performed in France in September 2021. Due to the nation's expanding healthcare infrastructure and rising government spending, which in turn drives the market, this number is anticipated to rise. Another driver in market expansion is the introduction of new products. For its CT scanner reading protocol created for COVID-19, Intrasense SA of Montpellier, France, acquired the CE certification in May 2020. This significant development coincided with the approval from the United States Food and Drug Administration, which will enable a mass rollout of the Myrian XP-Lung system created for COVID-19. Additionally, GE Healthcare in Paris, France, built a prefabricated cabin to house a CT system outside the entrance of the enormous Henri-Mondor Hospital in Créteil in December 2020. This helped in assessing disease progression and complications in COVID-19 patients while also facilitating patient flow throughout the facility. During the forecast period, market growth is anticipated to be fueled by such innovation in the studied industry.

However, it is projected that insufficient reimbursement and the expensive cost of equipment and CT scan processes will restrict market expansion in France.

France Computed Tomography Market Trends

This section covers the major market trends shaping the France Computed Tomography Market according to our research experts:

Oncology Segment is Expected to Hold a Significant Market Share Over the Forecast Period

France Computed Tomography Industry Segmentation

As per the scope of the report, computed tomography (CT) is an imaging process that customizes special X-ray equipment to generate a sequence of exhaustive images or scans of areas inside the body. It is also called computerized axial tomography (CAT) scanning, primarily used in cancer diagnosis. France Computed Tomography Market is segmented by Type (Low Slice, Medium Slice, and High Slice), Application (Oncology, Neurology, Cardiovascular, Musculoskeletal, and Other Applications), and End User (Hospitals, Diagnostic Centers, and Other End Users). The report offers the value (in USD million) for the above segments.